These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6799535)

  • 1. The effects of the gabaergic drug, sodium valproate, on prolactin secretion in normal and hyperprolactinemic subjects.
    Melis GB; Paoletti AM; Mais V; Mastrapasqua NM; Strigini F; Fruzzetti F; Guarnieri G; Gambacciani M; Fioretti P
    J Clin Endocrinol Metab; 1982 Mar; 54(3):485-9. PubMed ID: 6799535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological activation of gamma-aminobutyric acid-system blunts prolactin response to mechanical breast stimulation in puerperal women.
    Melis GB; Fruzzetti F; Paoletti AM; Mais V; Kemeny A; Strigini F; Boldrini A; Fioretti P
    J Clin Endocrinol Metab; 1984 Jan; 58(1):201-5. PubMed ID: 6417154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different sensitivity to sodium valproate in healthy, non-tumoral and tumoral hyperprolactinemic subjects.
    Sarnacchiaro F; Colao A; Merola B; Di Sarno A; Landi ML; Di Somma C; Ferone D; Tolino A; Lombardi G
    J Endocrinol Invest; 1997 Oct; 20(9):513-8. PubMed ID: 9413804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the GABAergic drug, sodium valproate, on the prolactin release evoked by pharmacological stimuli in normal women.
    Melis GB; Fruzzetti F; Paoletti AM; Mais V; Beneventi F; Trimarchi G; Fioretti P
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):245-52. PubMed ID: 6426828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of a low dose dopamine infusion on prolactin secretion in normal and hyperprolactinemic subjects.
    Serri O; Kuchel O; Buu NT; Somma M
    J Clin Endocrinol Metab; 1983 Feb; 56(2):255-9. PubMed ID: 6822635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
    Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
    J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
    Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
    Quigley ME; Judd SJ; Gilliland GB; Yen SS
    J Clin Endocrinol Metab; 1979 Apr; 48(4):718-20. PubMed ID: 429515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of the GABAergic drug, sodium valproate, to reduce basal plasma prolactin secretion in chronic schizophrenia.
    Monteleone P; Zontini G; Steardo L
    Psychoneuroendocrinology; 1985; 10(4):475-80. PubMed ID: 3003777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinemic patients with pituitary microadenoma.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 Mar; 50(3):427-30. PubMed ID: 7358828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of tissue responsiveness to angiotensin-II in hyperprolactinemic subjects.
    Arafah BM; Gordon NH; Salazar R; Douglas JG
    J Clin Endocrinol Metab; 1990 Jul; 71(1):60-6. PubMed ID: 2370301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid modulation of the gamma-aminobutyric acid-controlled inhibition of exercise-stimulated growth hormone and prolactin secretion in normal men.
    Coiro V; Volpi R; Maffei ML; Caiazza A; Caffarri G; Capretti L; Colla R; Chiodera P
    Eur J Endocrinol; 1994 Jul; 131(1):50-5. PubMed ID: 8038904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of hypothalamic-pituitary testing in hyperprolactinemia: prolactin responses to insulin hypoglycemia and arginine.
    Archer DF; Harger JH; Moore EE; Hough LJ
    Am J Obstet Gynecol; 1981 Nov; 141(5):556-61. PubMed ID: 7027794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional studies of dopamine control of prolactin secretion in normal women and women with hyperprolactinemic pituitary microadenoma.
    Quigley ME; Judd SJ; Gilliland GB; Yen SS
    J Clin Endocrinol Metab; 1980 Jun; 50(6):994-8. PubMed ID: 7372794
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolactin responsiveness to peptide histidine methionine-27 in normal subjects and hyperprolactinemic patients.
    Muratori M; Romano C; Gambino G; Faglia G
    Horm Res; 1994; 42(6):257-61. PubMed ID: 7698720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
    Kamoi K; Tchuchida I; Sato H; Tanaka R; Ishiguro T; Kaneko K; Iwasaki Y; Shibata A
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamines and pituitary function. 2. Prolactin response to different dopamine doses in normal cycling women and patients with prolactin-secreting pituitary tumors, both before and after endogenous catecholamine synthesis inhibition.
    Nicoletti I; Filipponi P; Fedeli L; Gregorini G; Ambrosi F; Sfrappini M; Santeusanio F; Brunetti P
    Horm Metab Res; 1984 Dec; 16(12):658-62. PubMed ID: 6441763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly.
    Orio F; Iovino M; Monteleone P; Agrusta M; Steardo L; Lombardi G
    Horm Metab Res; 1988 Nov; 20(11):701-4. PubMed ID: 2850985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid prolactin: a reflection of abnormal prolactin secretion in patients with pituitary tumors.
    Schroeder LL; Johnson JC; Malarkey WB
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1255-60. PubMed ID: 1002815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentric experience on the acute effect of nomifensine in hyperprolactinemic women.
    Minuto F; Barbarino A; Baviera G; Mazzocchi G; De Marinis L; Leonardi R; Bernasconi D; Menini E; Maira G; Anile C
    J Endocrinol Invest; 1984 Apr; 7(2):137-40. PubMed ID: 6725869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.